RedC Biotech

RedC BiotechRedC Biotech
RedC Biotech

RedC Biotech

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

2015Active5
Rate

About

RedC Biotech produces proprietary, donor-free, universal red blood cells designed to be suitable for almost every patient. This technology aims to provide unlimited, high-quality, and low-cost blood transfusions for life-saving treatments and advanced therapies, addressing the global shortage and complex supply chain of traditional blood donations.

Technology stack

detected 2026-06-28
EmailMicrosoft 365
Stack
Wix
Observability
Sentry
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does RedC Biotech do?

RedC Biotech produces proprietary, donor-free, universal red blood cells designed to be suitable for almost every patient. This technology aims to provide unlimited, high-quality, and low-cost blood transfusions for life-saving treatments and advanced therapies, addressing the global shortage and complex supply chain of traditional blood donations.

Where is RedC Biotech headquartered?

RedC Biotech is headquartered in San Diego, United States.

When was RedC Biotech founded?

RedC Biotech was founded in 2015.

What industry does RedC Biotech operate in?

RedC Biotech operates in Life Sciences, Biotech, Blood, HealthTech, Drug Discovery, Clinical Trials.

How many employees does RedC Biotech have?

RedC Biotech has approximately 5 people on record.

What is RedC Biotech's revenue?

StartupHub estimates RedC Biotech's annual revenue at $879K (range $476K to $1.4M, 64% confidence), based on comparable companies in the sector.